Abstract
Carcinoid heart disease (CHD) is a rare cardiac complication that occurs most commonly in patients with advanced neuroendocrine tumors and is a known sequela of carcinoid syndrome. Neuroendocrine tumors most widely associated with CHD include tumors in the small bowel, followed by lung, large bowel, pancreatic, appendiceal, and ovarian neoplasms. Carcinoid syndrome is a paraneoplastic syndrome caused by the release of serotonin and other substances from neuroendocrine tumors. It results in a spectrum of symptoms, including diarrhea, flushing, bronchospasm, and symptoms of congestive heart failure. Without treatment and for patients with advanced heart failure, the prognosis of CHD can be less than a year. Management of CHD is often challenging as patients typically present late, and the disease can progress rapidly. Therefore, optimal management of these patients requires close collaboration among various specialties to quantify disease burden, delay the progression of valvular disease, and determine the most effective surgical and medical management strategies depending on the cardiac manifestations to improve quality of life and reduce mortality. This involves a collaborative team, including cardiology and oncology, and often involves many other disciplines, including hepatobiliary and cardiovascular surgeons, endocrinologists, anesthesiologists, and gastroenterologists.
References
Albåge, A., & Montibello, M. (2021). Surgical aspects of valve replacement in carcinoid heart disease. Journal of Cardiac Surgery, 36(1), 290–294. https://doi.org/10.1111/jocs.15169
Alves, C., Mesquita, M., Silva, C., Soeiro, M., Hajjar, L., & Riechelmann, R. P. (2018). High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease. Ecancermedicalscience, 12, 879. https://doi.org/10.3332/ecancer.2018.879
Alizadehasl, A., Galeshi, B., Peighambari, M., Pouraliakbar, H., Moradian, M., & Hashemi, A. (2021). A forgotten diagnosis in right heart failure: A case report and literature review. Clinical Case Reports, 9(4), 2040–2047. https://doi.org/10.1002/ccr3.3938
Balanescu, D. V., Donisan, T., Lopez-Mattei, J., Hassan, S., Kim, P., Dasari, D.,…Iliescu, C. (2019). The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment. Oncology Letters, 17(5), 4126–4132. https://doi.org/10.3892/ol.2018.9732
Baron, T., Bergsten, J., Albåge, A., Lundin, L., Sörensen, J., Öberg, K., & Flachskampf, F. A. (2021). Cardiac imaging in carcinoid heart disease. JACC. Cardiovascular Imaging, 14(11), 2240–2253. https://doi.org/10.1016/j.jcmg.2020.12.030
Bhattacharyya, S., Davar, J., Dreyfus, G., & Caplin, M. E. (2007). Carcinoid heart disease. Circulation, 116(24), 2860–2865. https://doi.org/10.1161/circulationaha.107.701367
Bigler, M. R., Hunziker, L., Fausto de Marchi, S., Pilgrim, T., Windecker, C., & Seiler, S. C. (2020). Pulmonary artery pressure ventricularization in a patient with carcinoid heart disease. Journal of the American College of Cardiology: Case Reports, 2(8), 1200–1204. https://doi.org/10.1016/j.jaccas.2020.05.057
Bober, B., Saracyn, M., Kołodziej, M., Kowalski, K., Deptula-Krawcyk, E., Kapusta, W.,…Bil, J. (2020). Carcinoid heart disease: How to diagnose and treat in 2020? Clinical Medicine Insights: Cardiology, 14, 1–10. https://doi.org/10.1177/1179546820968101
Castillo, J., Silvay, G., & Weiner, M. (2018). Anesthetic management of patients with carcinoid syndrome and carcinoid heart disease: The Mount Sinai Algorithm. Journal of Cardiothoracic and Vascular Anesthesia, 32(2), 1023–1031. https://doi.org/10.1053/j.jvca.2017.11.027
Connolly, H. M., Hartzell, V., Schaff, H. V., Mullany, C. J., Abel, M. D., & Pellikka, P. A. (2002). Carcinoid heart disease: Impact of pulmonary valve replacement in right ventricular function and remodeling. Circulation, 106(12), I51–I56. https://doi.org/10.1161/01.cir.0000032884.55215.87
Davar, J., Connolly, H. M., Caplin, M. E., Pavel, M., Zacks, J., Bhattacharyya, S.,…Toumpanakis, C. (2017). Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: An Expert Statement. Journal of the American College of Cardiology, 69(10), 1288–1304. https://doi.org/10.1016/j.jacc.2016.12.030
Francis, J. (2022). Carcinoid heart disease [Lecture with powerpoint slides]. BMH Medical Journal. https://johnsonfrancis.org/professional/carcinoid-heart-disease/
Grozinsky-Glasberg, S., Davar, J., Hofland, J., Dobson, R., Prasad, V., Pascher, A.,…Toumpanakis, C. (2022). European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease. Journal of Neuroendocrinology, 34(7), e13146. https://doi.org/10.1111/jne.13146
Hassan, S. A., Palaskas, N. L., Agha, A. M., Iliescu, C., Lopez-Mattei, J., Chen, C.,…Yusuf, S. W. (2019). Carcinoid heart disease: A comprehensive review. Current Cardiology Reports, 21(11), 140. https://doi.org/10.1007/s11886-019-1207-8
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M.,…Yancy, C. W. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145(18). https://doi.org/10.1161/cir.0000000000001063
Jin, C., Sharma, A. N., Thevakumar, B., Majid, M., Al Chalaby, S., Takahashi, N.,…Amsterdam, E. A. (2021). Carcinoid heart disease: Pathophysiology, pathology, clinical manifestations, and management. Cardiology, 146(1), 65–73. https://doi.org/10.1159/000507847
Khay, K., Arous, S., Bentaoune, T., Drighil, A., & Habbal, R. (2018). Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: A case report. Journal of Medical Case Reports, 12(23), 1–5. https://doi.org/10.1186/s13256-018-1574-6
Laskaratos, F. M., Davar, J., & Toumpanakis, C. (2021). Carcinoid heart disease: A review. Current Oncology Reports, 23(4), 48. https://doi.org/10.1007/s11912-021-01031-z
Luthra, S., Olevano, C., Richens, T., Tsang, G. M. (2020). Percutaneous transcatheter valve-in-valve pulmonary and tricuspid replacement in carcinoid heart disease. Journal of the American College of Cardiology: Case Reports, 2(4), 533–536. https://doi.org/10.1016/j.jaccas.2019.11.089
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J.,…Moslehi, J. (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal, 43(41), 4229–4361. https://doi.org/10.1093/eurheartj/ehac244
Ram, P., Penalver, J. L., Lo, K. B. U., Rangaswami, J., & Pressman, G. S. (2019). Carcinoid heart disease: Review of current knowledge. Texas Heart Institute Journal, 46(1), 21–27. https://doi.org/10.14503/thij-17-6562
Reddy, Y. (2021). The hemodynamics of pericardial restraint in heart failure. Journal of the American College of Cardiology. https://www.acc.org/latest-in-cardiology/articles/2021/05/04/19/07/the-hemodynamics-of-pericardial-restraint-in-heart-failure
Rubin de Celis Ferrari, A. C., Glasberg, J., & Riechelmann, R. P. (2018). Carcinoid syndrome: Update on the pathophysiology and treatment. Clinics (Sao Paulo, Brazil), 73(suppl 1), e490s. https://doi.org/10.6061/clinics/2018/e490s
Sanchez-Nadales, A., Celis-Barreto, V., Anampa-Guzman, A., Salazar-Leon, M., & Contreras-Cavez, P. (2020). Carcinoid right heart disease. Journal of Medical Cases, 11(3), 73–76. https://doi.org/10.14740/jmc3452
Sharma, A., Fierro, M. E., Pak, S., Thallapureddy, K., Awoajo, M., & Otchere, P. (2023). Late stage diagnosis of carcinoid heart disease due to lack of access to health care. Cardiooncology, 9(28). https://doi.org/10.1186/s40959-023-00176-z
Steeds, R., Sagar, V., Shetty, S., Oelofse, T., Singh, H., Ahmad, R.,…Shah, T. (2019). Multidisciplinary team management of carcinoid heart disease. Endocrine Connections, 8(12), R184–R199. https://doi.org/10.1530/EC-19-0413
Subash, N., Papali, M. M., Bahadur, K. P., Avanthika, C., Jhaveri, S., Thannir, S.,…Valisekka, S. S. (2022). Recent advances in the diagnosis and management of carcinoid syndrome. Disease-a-month: DM, 68(7), 101304. https://doi.org/10.1016/j.disamonth.2021.101304
Uema, D., Alves, C., Mesquita, M., Nuñez, J. E., Siepmann, T., Angel, M.,…Riechelmann, R. P. (2019). Carcinoid heart disease and decreased overall survival among patients with neuroendocrine tumors: A retrospective multicenter Latin American cohort study. Journal of Clinical Medicine, 8(3), 405. https://doi.org/10.3390/jcm8030405
